These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24471664)

  • 21. The sevoflurane washout profile of seven recent anesthesia workstations for malignant hyperthermia-susceptible adults and infants: a bench test study.
    Cottron N; Larcher C; Sommet A; Fesseau R; Alacoque X; Minville V; Fourcade O; Kern D
    Anesth Analg; 2014 Jul; 119(1):67-75. PubMed ID: 24806140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The temperature-humidity profile of the PhysioFlex. Studies on a model].
    Wissing H; Kuhn I; Kessler P
    Anaesthesist; 1997 Mar; 46(3):201-6. PubMed ID: 9163264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accelerating the washout of inhalational anesthetics from the Dräger Primus anesthetic workstation: effect of exchangeable internal components.
    Crawford MW; Prinzhausen H; Petroz GC
    Anesthesiology; 2007 Feb; 106(2):289-94. PubMed ID: 17264723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparing charcoal and zeolite reflection filters for volatile anaesthetics: A laboratory evaluation.
    Sturesson LW; Frennström JO; Ilardi M; Reinstrup P
    Eur J Anaesthesiol; 2015 Aug; 32(8):521-6. PubMed ID: 25387299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation of the Dräger Primus anesthetic machine for malignant hyperthermia-susceptible patients.
    Prinzhausen H; Crawford MW; O'Rourke J; Petroz GC
    Can J Anaesth; 2006 Sep; 53(9):885-90. PubMed ID: 16960266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation of the Dräger Fabius GS workstation for malignant hyperthermia-susceptible patients.
    Whitty RJ; Wong GK; Petroz GC; Pehora C; Crawford MW
    Can J Anaesth; 2009 Jul; 56(7):497-501. PubMed ID: 19399571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eltanolone (5-beta-pregnanolone) does not trigger, and attenuates halothane triggering of, malignant hyperthermia in malignant hyperthermia susceptible swine.
    Harrison GG; Dyer RA; Llewellyn RL; James MF
    Pharmacol Res; 1999 Feb; 39(2):103-6. PubMed ID: 10072700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response by the authors, reflection of volatile anesthetic by the vapor-clean filter.
    Müller-Wirtz LM; Meiser A; Kermad A; Godsch C; Sessler DI; Volk T; Kreuer S; Hüppe T
    Acta Anaesthesiol Scand; 2020 Oct; 64(9):1383-1384. PubMed ID: 32686079
    [No Abstract]   [Full Text] [Related]  

  • 29. [Halothane absorption by dry soda lime].
    Stuttmann R; Knüttgen D; Müller MR; Winkert AT; Doehn M
    Anaesthesist; 1993 Mar; 42(3):157-61. PubMed ID: 8480902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malignant hyperthermia: removal of volatile anesthetic agents from the breathing circuit using activated charcoal.
    Greene ER
    Anesthesiology; 1986 Aug; 65(2):240-1. PubMed ID: 3740531
    [No Abstract]   [Full Text] [Related]  

  • 31. Malignant hyperthermia: pharmacology of triggering.
    Hopkins PM
    Br J Anaesth; 2011 Jul; 107(1):48-56. PubMed ID: 21624965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adsorption of anaesthetic vapours on charcoal beds.
    Maggs FA; Smith ME
    Anaesthesia; 1976; 31(1):30-40. PubMed ID: 1259121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Administration of anaesthetic triggering agents to patients tested malignant hyperthermia normal and their relatives in New Zealand: an update.
    Frei D; Stowell KM; Langton EE; McRedmond L; Pollock NA; Bulger TF
    Anaesth Intensive Care; 2017 Sep; 45(5):611-618. PubMed ID: 28911291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Removal of halogenated anaesthetics from a closed circle system with a charcoal filter.
    Højkjaer Larsen V; Severinsen I; Waaben J
    Acta Anaesthesiol Scand; 1989 Jul; 33(5):374-8. PubMed ID: 2800974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Muscle biopsy for malignant hyperthermia screening in children.
    Ummenhofer W; Roesslein R; Sutter PM; Moser N; Kern C; Urwyler A
    Eur J Pediatr Surg; 1997 Oct; 7(5):259-62. PubMed ID: 9402480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation of the Siemens KION anesthetic machine for patients susceptible to malignant hyperthermia.
    Petroz GC; Lerman J
    Anesthesiology; 2002 Apr; 96(4):941-6. PubMed ID: 11964603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Charcoal and isoflurane alveolar washout in low-flow circuit].
    Romano E; Pegoraro M; Vacri A; Pecchiari C; Auci E
    Minerva Anestesiol; 1993 May; 59(5):223-7. PubMed ID: 8355862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of volatile anaesthetic agents on the filtration performance of paediatric breathing system filters.
    Froom SR; Cann C; Wilkes AR; Gildersleve C; Hall JE
    Anaesthesia; 2008 Jan; 63(1):77-81. PubMed ID: 18086074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anesthesiologic management of susceptible children at risk for malignant hyperthermia].
    Ferrari F; D'Alessandro S; Pietrandrea G; Villani A
    Minerva Anestesiol; 1997 Oct; 63(10):311-4. PubMed ID: 9567608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of exposure of malignant hyperthermia non-susceptible patients and their relatives to anaesthetic triggering agents.
    Pollock N; Langton EE; Stowell KM; Bulger TF
    Anaesth Intensive Care; 2011 Sep; 39(5):887-94. PubMed ID: 21970134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.